The hepatitis C virus (HCV) causes hepatitis C, a liver disease. The virus causes both acute and chronic hepatitis which could range from severe to mild illness, lasting for a few weeks or can extend to a serious life-long illness. This disease is a major cause of liver cancer. It is a blood-borne virus and it is estimated that 71 million people have chronic hepatitis C infection globally. Antiviral medicines are said to cure nearly 95% of people with hepatitis C but currently, there is no effective vaccine against the infection. An estimated 2.4 million people in the country are living with hepatitis C viral infection. The World Health Organization (WHO) aims to eliminate HCV as a public health threat by 2030.
The following people have an increased risk of HCV infection:
Contributors to the hepatitis C virus are usually certain risk factors that cause hepatitis C. HCV is primarily transmitted through parenteral exposures to body fluids that contain blood or infectious blood.
Some of the few contributors to hepatitis C are as follows:
According to a multi-state review of global HCV infection prevalence in 2017, it is said that this disease ranges from 38.1% to 68.0% in our country. There is limited data regarding the contributors of hepatitis C with regards to illegal drug use. Due to the more advanced screening test, the contributor of hepatitis C through blood transfusion has greatly reduced after 1992.
Medical and dental procedures performed in the country generally do not pose a risk for the contribution of hepatitis C as long as standard precautions and other infection control practices are used consistently. Hepatitis C contributors can be within a household too but do not occur often. It spreads most likely due to a result of direct parenteral or percutaneous exposure to the blood of an infected household member.